论文信息 - Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial - 字舞流文

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

D. Podzamczer | B. Clotet | H. Stellbrink | Y. Yazdanpanah | M. Murray | J. Eron | J. Angel | J. Mrus | Kimberly Smith | H. Crauwels | W. Spreen | D. Margolis | J. González-García | T. Lutz | S. Ford | P. Patel | M. S. Clair | G. Richmond | D. Dorey | Sandy Griffith | K. Sutton | P. Williams | L. Sloan | Félix Gutiérrez | F. Gutiérrez